Solstice Advanced Materials Inc.
SOLS Basic Materials Specialty Chemicals
Solstice Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 3.08% from fiscal 2024.
- Revenue
- +7.95%
- EPS
- −11.1%
- Free cash flow
- +276.3%
- Total debt
- +1,805.6%
Quarter to September 2026, against a year earlier
Follow SOLS
Alert me
Solstice Advanced Materials Inc. (SOLS) EBITDA
Solstice Advanced Materials Inc.'s EBITDA for fiscal 2025 was $835.0M, down 18.3% from $1.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $809.0M. Solstice Advanced Materials Inc. ranks 15th of 59 Specialty Chemicals companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $835.0M | (18.30%) |
| FY2024 | $1.0B | (2.11%) |
| FY2023 | $1.0B | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $255.0M | 18.06% |
| Mar 2026 | $216.0M | 44.97% |
| Dec 2025 | $149.0M | (21.16%) |
| Sep 2025 | $189.0M | (27.86%) |
| 3 more quarters | Free account |
EBITDA against peers
| Company | EBITDA |
|---|---|
| SSL Sasol Ltd. compare | $9.9B |
| EMN Eastman Chemical Company compare | $1.4B |
| ALB Albemarle Corporation compare | $1.3B |
| SQM Sociedad Quimica y Minera S.A. compare | $1.1B |
| AXTA Axalta Coating Systems Ltd. compare | $958.0M |
| SOLS Solstice Advanced Materials Inc. | $809.0M |
| WLK Westlake Corporation compare | $721.0M |
| NEU NewMarket Corporation compare | $686.5M |
| ESI Element Solutions Inc. compare | $578.2M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on SOLS
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement